Only as available as its most restricted ingredient, here, Selank, which is education-only.
The Cognition Stack
The default nootropic-peptide pair, Semax for pro-cognitive / BDNF effects, Selank for a calming, anti-anxiety effect. Often described as ‘focused calm.’
Last reviewed June 16, 2026.
The honest answer
This is the default nootropic-peptide pair: Semax for a pro-cognitive, BDNF-leaning effect and Selank for a calming, anti-anxiety effect, together described as ‘focused calm.’ Both have a long history of use outside the US and thin Western evidence, and the pair has never been trial-tested as a combination. Our catalog under-serves cognition today, and we'd rather say so than invent an offer.
- Both have a long history of use outside the US for cognitive and neurological conditions.
- Semax is the more-studied of the pair.
- US clinical evidence is limited.
- The pair has not been trial-tested as a combination, most of what circulates is anecdote.
Go deeper
The concept pairs Semax (focus, BDNF) with Selank (calm, anxiolytic) to get ‘focused calm’, stimulation balanced against anxiety reduction. It's a popular idea with a long anecdotal history abroad and little Western trial data, and none on the pair as a combination. As always, what fits a given person is a clinical question, not a protocol we publish.
No doses, no protocols. If a legitimate cognition option fits, a clinician maps it; where there isn't one yet, we say so.
Status & access
Semax is on the July 24, 2026 PCAC agenda (advisory); Selank is education-only. Our catalog under-serves cognition right now, we'll point you to the closest legitimate option and flag honestly where there isn't one yet (the SKU gap).
Compounded medications are prepared for an individual patient and are not FDA-approved. Removal from FDA Category 2 (April 2026) is not approval and not 503A Bulks-List eligibility. PCAC is advisory, a favorable vote leads to rulemaking, not instant availability.
No doses, no protocols. If a legitimate cognition option fits, a clinician maps it; where there isn't one yet, we say so.
Questions, answered first
What is the Semax Selank stack?
It's the default nootropic-peptide pair, Semax for a pro-cognitive/BDNF effect and Selank for a calming, anti-anxiety effect, together called ‘focused calm.’ It's an anecdotal community pairing, not a trial-tested combination, and we treat it as education.
Is Semax legal in 2026?
Semax is on the FDA's PCAC agenda for July 24, 2026, which is advisory, a review step, not approval or availability. It is not something we offer today. Selank, its usual partner, is education-only.
Are there legal nootropic peptides?
The honest answer is that cognition is under-served right now: most nootropic peptides are education-only or under review, and the pair here has only anecdotal, mostly non-US evidence. Rather than invent an offer, we flag the gap and point to the closest legitimate option when one fits.